Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes

• Main Authors: Navya Varshney (Author), Sarah J. Billups (Author), Joseph J. Saseen (Author), Cy W. Fixen (Author)
• 格式: 图书
• 出版: SAGE Publishing, 2021-03-01T00:00:00Z.
• 主题: article
• 在线阅读: Connect to this object online.

Background and aims: Although landmark clinical trials have demonstrated an increased risk for genitourinary infection (GUI) after initiation of sodium-glucose cotransporter-2 inhibitor (SGLT2i) therapy that led to an FDA label warning, real world findings have been inconsistent and evidence specifi...